ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1106 • ACR Convergence 2023

    Monosodium Urate and Calcium Pyrophosphate Crystal-induced Inflammation Relies on Cell Volume Regulation and LRRC8/VRAC Channel Activation

    Twinu Wilson Chirayath1, mete kayatekin2, Isabelle Rubera3, Nghia Pham4, FREDERIC LIOTE4, Pascal Richette5, Vincent COMPAN6, François Rassendren7, Christophe Duranton3 and Hang Korng EA4, 1INSERM, Paris, France, 2CNRS-UMR7370, Nice, France, 3CNRS-UMR 7370, Nice, France, 4INSERM-BIOSCAR, Paris, France, 5Lariboisière Hospital, Paris, France, 6CNRS-IGF, Montpellier, France, 7CNRS UMR 5203, Montpellier, France

    Background/Purpose: Monosodium urate (MSU) and calcium pyrophosphate (CPP) crystals are responsible for interleukin (IL)-1β dependent acute arthritis. The release of mature IL-1β is dependent on…
  • Abstract Number: 1095 • ACR Convergence 2023

    Engagement with the RISE Registry Clinician Dashboard Is Associated with Higher Performance on Rheumatology Quality Measures

    Emma Kersey1, Jing Li1, Julia Kay1, Julia Adler-Milstein1, Jinoos Yazdany2 and Gabriela Schmajuk3, 1University of California San Francisco, San Francisco, CA, 2University of California, General Department of Medicine, Division of Rheumatology, San Francisco, CA, 3UCSF / SFVA, San Francisco, CA

    Background/Purpose: The American College of Rheumatology's Rheumatology Informatics System for Effectiveness (RISE) EHR-based registry facilitates quality measure calculation and reporting for rheumatology practices in national…
  • Abstract Number: 1111 • ACR Convergence 2023

    Urate-Lowering Therapy Is Associated with a Reduced Risk of Arrhythmias: A Systematic Review and Meta-analysis

    Palapun Waitayangkoon1, Tatchaya Kanthajan2 and Thiratest Leesutipornchai3, 1MetroWest Medical Center, Framingham, MA, 2Srinakharinwirot University, Bangkok, Thailand, 3University of Hawaii, Honolulu, HI

    Background/Purpose: Recent studies have suggested that hyperuricemia is significantly associated with an increased prevalence of atrial and ventricular arrhythmias and urate-lowering therapy (ULT) may provide…
  • Abstract Number: 1114 • ACR Convergence 2023

    Role of Dual-energy Computed Tomography (DECT) in Detection of Carotid Artery Monosodium Urate Deposition in Patients with Gout

    Muhammad Danish Sarfraz, Lee Treanor, Savvas Nicolaou and Adnan Sheikh, University of British Columbia, Vancouver, BC, Canada

    Background/Purpose: To find out if a Dual energy CT can detect monosodium urate deposition in carotid arteries and whether the presence of monosodium urate crystals…
  • Abstract Number: 1080 • ACR Convergence 2023

    Prevalence and Incidence of Paradoxical Side-effects of TNF-α Inhibitors: A Cross-sectional Study

    Antoine Minier1, Gilles Boire1, Sophie ROUX1, Nathalie Carrier2 and Hugues Allard-Chamard1, 1Université de Sherbrooke, Sherbrooke, QC, Canada, 2CIUSSS de l'Estrie - CHUS, Sherbrooke, QC, Canada

    Background/Purpose: Tumor necrosis factor alpha inhibitors (TNFi) are used to treat a variety of inflammatory conditions ranging from rheumatoid arthritis to sarcoidosis. Paradoxical side-effects (PSE)…
  • Abstract Number: 1050 • ACR Convergence 2023

    Diagnostic Accuracy of Lung Ultrasound for Detecting Interstitial Lung Disease Among Patients with Systemic Sclerosis: A Comparative Study of Two Scanning Protocols

    Fabian Carranza Enriquez1, Carina Soto-Fajardo1, Sinthia Solorzano Flores1, Abish Angeles-Acuña1, Mayra Mejia-Avila2, Amyrari Vázquez-Ortega3, Paola Flores-Ordoñez2, Karina Arias Callejas2, Alejandra Enriquez-Luna4, Graciliano Ramon-Diaz4, Brenda Bravo-Zarate2, Tatiana Sofía Rodríguez-Reyna3 and Carlos Pineda4, 1Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Mexico City, Mexico, 2Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Mexico City, Mexico, 3Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 4Instituto Nacional de Rehabilitacion, Mexico City, Mexico

    Background/Purpose: Lung ultrasound (LUS) has proven useful to detect interstitial lung disease (ILD) among patients with SSc when compared to high-resolution computerized tomography (HRCT) as…
  • Abstract Number: 1117 • ACR Convergence 2023

    Serum Urate Change Among Gout Patients Initiating Sodium-Glucose Cotransporter Type 2 Inhibitors (SGLT2i) vs. Sulfonylureas: A Comparative Effectiveness Analysis

    Chio Yokose1, Gregory Challener2, Baijun Zhou2, Natalie McCormick2, Sruthi Tanikella2, Kila Panchot2, Minna Kohler3, Janeth Yinh2, Yuqing Zhang4, David Bates5, James Januzzi2, Meghan Sise2, Deborah Wexler2 and Hyon K. Choi6, 1Massachusetts General Hospital, Waltham, MA, 2Massachusetts General Hospital, Boston, MA, 3Massachusetts General Hospital, Harvard Medical School, Boston, MA, 4Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, MA, 5Brigham and Women's Hospital, Boston, MA, 6Massachusetts General Hospital and Harvard Medical School, Lexington, MA

    Background/Purpose: Sodium-glucose cotransporter type 2 inhibitors (SGLT2i) are currently indicated as second-line therapy for type 2 diabetes and are also approved for the treatment of…
  • Abstract Number: 1101 • ACR Convergence 2023

    Systemic Inflammation Associated with Silent Deposition of Monosodium Urate Crystals in Asymptomatic Hyperuricemia

    Maria-Luisa Peral-Garrido1, Paula Boix-Navarro2, Silvia Gómez-Sabater3, Rocío Caño-Alameda3, Alejandra Bermúdez-García4, Teresa Lozano4, Ruth Sanchez-Ortiga4, Miguel Perdiguero4, Elena Caro-Martínez5, Carolina Ruiz-García6, Eliseo Pascual4, Rubén Francés2 and Mariano Andrés4, 1Vinalopó University Hospital, Novelda, Spain, 2Miguel Hernandez University, San Juan de Alicante, Spain, 3Rheumatology Department, Dr. Balmis University General Hospital, Alicante. Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain, 4Dr Balmis Alicante General University Hospital-ISABIAL, Alicante, Spain, 5San Vicente Hospital-HACLE, San Vicente del Raspeig, Spain, 6Campoamor Health Centre, Alicante, Spain

    Background/Purpose: Whether the presence of subclinical monosodium urate (MSU) crystal deposition leads to a pro-inflammatory state in asymptomatic hyperuricemia (AH) is unknown. We aimed to…
  • Abstract Number: 1086 • ACR Convergence 2023

    Increase Shingrix Vaccination Rate in Patients on JAK Inhibitors: A Quality Improvement Project at the Rheumatology Practice of an Urban Institution

    Jin Feng1 and Kristaq Koci2, 1Icahn School of Medicine at Mount Sinai Morningside and West, New York, NY, 2Icahn School of Medicine at Mount Sinai Morningside and West, Bronx, NY

    Background/Purpose: The 2022 ACR guidelines for vaccination strongly recommend recombinant VZV vaccination for all patients > 18 years old who are taking immunosuppressive medication. Studies…
  • Abstract Number: 1112 • ACR Convergence 2023

    AR882, a Potent Uricosuric Agent, Shows Favorable Uric Acid Excretion Profile Following Multiple Doses

    Zancong Shen1, Elizabeth Polvent2, sarah Morris3, Rongzi Yan4, Shunqi Yan5, Robert Keenan6 and Li-Tain Yeh7, 1Arthrosi Therapeutics, San Diego, CA, 2Arthrosi Therapeutics, Inc., Roseville, CA, 3Arthrosi Therapeutics Inc, San Diego, CA, 4Arthrosi Therapeutics, Inc, Irvine, CA, 5Arthrosi Therapeutics, Inc., Laguna Hills, CA, 6Arthrosi Therapeutics, Chapel Hill, NC, 7Arthrosi Therapeutics, Inc., Irvine, CA

    Background/Purpose: The uric acid transporter inhibitor (URAT1) is responsible for the reabsorption of filtered uric acid from the renal tubular lumen. Uricosuric agents inhibit URAT1…
  • Abstract Number: 1109 • ACR Convergence 2023

    Genetic Risk Variants in Hyperuricemia and Gout: Common Disease, Multiple Common and Rare Variant Hypothesis

    Blanka Stiburkova1, Katerina Pavelcova2, Jana Masinova1, Marketa Pavlikova3 and Karel Pavelka4, 1Institute of Rheumatology, Prague, Czech Republic, 2Institute of Rheumatology, Praha 2, Czech Republic, 3Department of Probability and Mathematical Statistics, Faculty of Mathematics and Physics, Charles University, Prague, Czech Republic, 4Institut of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Praha, Czech Republic

    Background/Purpose: Hyperuricemia is a central feature in the pathogenesis of gout. Hyperuricemia results from an imbalance between endogenous production and excretion of urate; however, the…
  • Abstract Number: 1108 • ACR Convergence 2023

    Minimal Clinically Important Difference (MCID) of Quality of Life Assessments in Patients with Uncontrolled Gout

    Brian LaMoreaux1, Chelsea McKibbon2, Katie Obermeyer1, Lissa Padnick-Silver1, Gerald Smith2, Jiaxuan Wang2 and Haridarshan Patel1, 1Horizon Therapeutics, Deerfield, IL, 2Cytel Inc., Vancouver, BC, Canada

    Background/Purpose: Gout is an inflammatory arthritis that results in severe joint inflammation, pain, disability, and lower quality of life (QoL). Determining minimal clinically important differences…
  • Abstract Number: 1115 • ACR Convergence 2023

    EULAR Recommendations for the Use of Imaging in the Diagnosis and Management of Crystal-induced Arthropathies in Clinical Practice

    Peter Mandl1, Maria-Antonietta D'Agostino2, Victoria Navarro-Compán3, Irina Gessl1, Garifallia Sakellariou4, Abhishek Abhishek5, Fabio Becce6, Nicola Dalbeth7, Hang-Korng Ea8, Emilio Filippucci9, Hilde Berner Hammer10, Annamaria Iagnocco11, Annette De Thurah12, Esperanza Naredo13, Sebastien Ottaviani14, Tristan Pascart15, Fernando Perez-Ruiz16, Irene Pitsillidou17, Fabian Proft18, Juergen Rech19, Wolfgang Schmidt20, Luca Sconfienza21, Lene Terslev22, Brigitte Wildner23, Pascal Zufferey24 and Georgios Filippou25, 1Department of Rheumatology, Medical University of Vienna, Vienna, Austria, 2Universita Cattolica del Sacro Cuore Rome, Courbevoie, France, 3Department of Rheumatology, La Paz University Hospital, IdiPaz, Madrid, Spain, 4Department of Internal Medicine and Therapeutics, Università di Pavia, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy, 5University of Nottingham, Nottingham, United Kingdom, 6Lausanne University Hospital (CHUV), Lausanne, Switzerland, 7University of Auckland, Auckland, New Zealand, 8Hôpital Lariboisière, APHP-Nord, Service de Rhumatologie, Université de Paris Cité, Paris, France, 9Polytechnic University of Marche, Jesi, Italy, 10Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway AND University of Oslo, Faculty of Medicine, Oslo, Norway, 11University of Turin, Roma, Italy, 12Aarhus University Hospital, Aarhus, Denmark, 13Hospital Fundación, Madrid, Spain, 14Assistance Publique Hopitaux de Paris, Paris, France, 15Department of Rheumatology, Saint-Philibert Hospital, Lille Catholic University, Lille, France, 16Rheumatology Division, Osakidetza, OSI-EE Cruces, Cruces University Hospital, Barakaldo, Spain, 17EULAR Patient Research Partner, Executive Secretary of Cyprus League Against Rheumatism, Nicosia, Cyprus, 18Department of Gastroenterology, Infectiology and Rheumatology (including Nutrition Medicine), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, 19University Clinic Erlangen, Erlangen, Germany, 20Rheumatology, Immanuel Krankenhaus Berlin, Medical Centre for Rheumatology Berlin-Buch, Berlin, Germany, 21Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano AND IRCCS Istituto Ortopedico Galeazzi, 20161, Milan, Italy, 22Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Denmark, 23University Library, Medical University of Vienna, Vienna, Austria, 24Rheumatology Department, University of Lausanne, CHUV, Lausenne, Switzerland, 25IRCCS Galeazzi - Sant'Ambrogio Hospital, Milan, Italy

    Background/Purpose: The multifaceted clinical presentation in crystal-induced arthropathies (CiA) poses challenges to imaging. Our goal was to formulate evidence-based recommendations on the use of imaging…
  • Abstract Number: 1105 • ACR Convergence 2023

    Effects of Uric Acid Lowering Treatment on Vascular Stiffness in Gout Patients

    Jinseok kim, Division of Rheumatology, Department of Internal Medicine, Jeju National University Hospital, Jeju National University School of Medicine, Jeju, South Korea

    Background/Purpose: Many studies have reported that gout and hyperuricemia are associated with an increase in all-cause mortality and cardiovascular mortality.Increased vascular stiffness is closely related…
  • Abstract Number: 1064 • ACR Convergence 2023

    Seroconversion Rates in Rituximab-Treated Rheumatic Patients Receiving COVID-19 Vaccination

    Ryan Wilson1, Junaid Awan2, Mary Brady2, Ciara Hunt2, Fahd Adeeb3 and alexander fraser4, 1University of Limerick, Buncrana, Ireland, 2University of Limerick, Limerick, Ireland, 3RCSI & UCD (Ireland) Malaysia Campus (RUMC), Malaysia, Malaysia, 4HSE, Limerick, Ireland

    Background/Purpose: COVID-19 has increased the mortality rates among rheumatic patients, mainly those immunocompromised or with underlying comorbidities. During the COVID-19 vaccine development, patients on immunomodulatory…
  • « Previous Page
  • 1
  • …
  • 368
  • 369
  • 370
  • 371
  • 372
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology